Zomedica Corp (AMEX:ZOM) price on current trading day, fall -0.46% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.13.
A look at the stock’s price movement, the level at last check in today’s session was $0.13, moving within a range at $0.1274 and $0.1305. The beta value (5-Year monthly) was 1.064. Turning to its 52-week performance, $0.23 and $0.12 were the 52-week high and 52-week low respectively. Overall, ZOM moved 6.98% over the past month.
Zomedica Corp’s market cap currently stands at around $126.22 million, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 8.1M for the company’s revenue for the quarter, with a low and high estimate of 8.1M and 8.1M respectively.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ZOM is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend ZOM as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ZOM’s current price about -0.97% and 0.80% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 50.30, while 7-day volatility ratio is 3.54% and 5.50% in the 30-day chart. Further, Zomedica Corp (ZOM) has a beta value of 1.06, and an average true range (ATR) of 0.01.
If we refocus on Zomedica Corp (AMEX:ZOM), historical trading data shows that trading volumes averaged 4.42 over the past 10 days and 4.70 million over the past 3 months. The company’s latest data on shares outstanding shows there are 979.95 million shares.
The 1.76% of Zomedica Corp’s shares are in the hands of company insiders while institutional holders own 8.27% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 51.14 million on 2024-10-15, giving us a short ratio of 17.24. The data shows that as of 2024-10-15 short interest in Zomedica Corp (ZOM) stood at 521.0 of shares outstanding, with shares short rising to 43.37 million registered in 2024-09-13. Current price change has pushed the stock -35.66% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ZOM stock continues to rise going into the next quarter.
